Alzheimer's Disease Imaging With PET/MRI - Beta-amyloid

Inclusion Criteria

• •Patients with suspected AD, MCI and other cognitive impairment will be referred by their neurologist to have a clinical ordered FDG-PET/CT and clinically indicated AMYVID in addition,
• •Patients equal to or greater than 21 years old,
• •Signed informed consent by patient or legal guardian,
• •Physically capable to cooperate.
• •Subjects unwilling or unable to sign the informed consent form,
• •Subjects with any significant psychiatric or neurologic disorder or disease other than dementia expected to interfere with the study,
• •Subjects unable to undergo MR scanning due to exclusion via UHCMC MR restrictions (e.g. certain implanted metallic or electronic devices),
• •History of adverse events related to a previous MR or PET/CT,
• •Pregnant women,
• •Minors.